| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Deflazacort |
地夫可特 |
14484-47-0 |
詳細
|
| prednisolon |
潑尼松龍 |
50-24-8 |
詳細
|
| 11α-Hydroxyprogesterone |
11ALPHA-孕酮 |
80-75-1 |
詳細
|
| Fludrocortisone acetate |
醋酸氟氫可的松 |
514-36-3 |
詳細
|
| Hydrocortisone 17-valerate |
氫化可的松-17-戊酸酯 |
57524-89-7 |
詳細
|
| cortisol sodium phosphate |
氫化可的松磷酸鈉 |
6000-74-4 |
詳細
|
| Hydrocortisone-17-butyrate |
丁酸氫化可的松 |
13609-67-1 |
詳細
|
| Triamcinolone Acetonide EP Impurity E |
氫化曲安奈德 |
1524-86-3 |
詳細
|
| triamcinolone acetonide |
曲安奈德 |
76-25-5 |
詳細
|
| Triamcinolone |
曲安西龍 |
124-94-7 |
詳細
|
| Budesonide |
布地奈德 |
51372-29-3 |
詳細
|
| Gepotidacin |
吉泊達星 |
1075236-89-3 |
詳細
|
| Hydrocortisone Sodium Succinate |
氫化可的松琥珀酸鈉 |
125-04-2 |
詳細
|
| Cortisone |
可的松 |
53-06-5 |
詳細
|
| Prednisolone phosphate sodium |
潑尼松龍磷酸鈉 |
125-02-0 |
詳細
|
| Prednisone Phosphate Disodium Salt/17-Hydroxy-21-(phosphonooxy)pregna-1,4-diene-3,11,20-trione disodium salt |
Pregna-1,4-diene-3,11,20-trione, 17-hydroxy-21-(phosphonooxy)-, disodium salt |
33903-70-7 |
詳細
|
| BEMPEDOIC ACID |
貝派度酸API |
738606-46-7 |
詳細
|
| Prednisolone Hemisuccinate |
潑尼松龍半琥珀酸酯 |
2920-86-7 |
詳細
|
| Difluprednate |
二氟潑尼酯 |
23674-86-4 |
詳細
|
| loteprednol etabonate |
依碳氯替潑諾 |
82034-46-6 |
詳細
|
| Prednisolone Valeroacetate |
潑尼松龍醋酸戊酸酯 |
72064-79-0 |
詳細
|
| Anecortave Acetate |
醋酸阿奈可他 |
7753-60-8 |
詳細
|
| Clascoterone |
克拉司酮 |
19608-29-8 |
詳細
|
| ZN-c3 |
ZN-c3 |
2376146-48-2 |
詳細
|
| Fmoc-N'-methyltrityl-L-lysine |
Fmoc-N'-甲基三苯甲基-L-賴氨酸 |
167393-62-6 |
詳細
|
| 1H-1,4-Benzodiazepine-2-methanamine, 7-chloro-2,3-dihydro-5-phenyl- |
雜質(zhì) |
138729-68-7 |
詳細
|
| NA |
|
58468-07-4 |
詳細
|
| MK-1775 |
MK-1775 |
955365-80-7 |
詳細
|
| IAG933 |
IAG933 |
2714434-21-4 |
詳細
|
| 8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)- |
化合物 CC-99677 |
1887069-10-4 |
詳細
|
| Bermekimab |
BERMEKIMAB (貝邁奇單抗 ) |
1401965-15-8 |
詳細
|
| Research Grade Nemolizumab |
奈莫利珠單抗 |
1476039-58-3 |
詳細
|
| Isatuximab |
艾薩妥昔單抗 |
1461640-62-9 |
詳細
|
| Lilotomab |
Lilotomab |
1453362-55-4 |
詳細
|
| Indusatumab |
英度妥單抗 |
1497400-26-6 |
詳細
|
| Navivumab |
Navivumab |
1443004-16-7 |
詳細
|
| Pepinemab |
PEPINEMAB (派比奈單抗 ) |
2097151-87-4 |
詳細
|
| Obiltoxaximab |
Obiltoxaximab |
1351337-07-9 |
詳細
|
| Rovalpituzumab |
洛伐妥珠單抗 |
1613313-01-1 |
詳細
|
| Istiratumab |
Istiratumab |
1509928-04-4 |
詳細
|
| Research Grade Cergutuzumab |
Cergutuzumab Amunaleukin |
1509916-03-3 |
詳細
|
| Trevogrumab |
Trevogrumab |
1429201-24-0 |
詳細
|
| Inebilizumab |
Inebilizumab |
1299440-37-1 |
詳細
|
| Brolucizumab |
Brolucizumab |
1531589-13-5 |
詳細
|
| Tesidolumab |
Tesidolumab |
1531594-08-7 |
詳細
|
| Elgemtumab |
Elgemtumab |
1512559-37-3 |
詳細
|
| Andecaliximab |
Andecaliximab |
1518996-49-0 |
詳細
|
| Indusatumab Vedotin |
Indusatumab Vedotin |
1514889-12-3 |
詳細
|
| Sevirumab |
司韋單抗 |
138660-96-5 |
詳細
|
| 4-[4-(4-amino-1,2,5-oxadiazol-3-yl)-2-oxido-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine |
2'-氧基-[3,3' |
296244-55-8 |
詳細
|
| Meplazumab |
Meplazumab |
2413715-21-4 |
詳細
|
| Rinucumab |
Rinucumab |
1569263-06-4 |
詳細
|
| Depatuxizumab |
Depatuxizumab |
1471999-69-5 |
詳細
|
| Suptavumab |
Suptavumab |
1629615-23-1 |
詳細
|
| Birtamimab |
Birtamimab |
1608108-91-3 |
詳細
|
| Erenumab |
厄瑞努單抗 |
1582205-90-0 |
詳細
|
| Fremanezumab |
瑞瑪奈珠單抗 |
1655501-53-3 |
詳細
|
| Burosumab |
Burosumab |
1610833-03-8 |
詳細
|
| Afasevikumab |
Afasevikumab |
1589503-30-9 |
詳細
|
| Tisotumab |
Tisotumab |
1418628-81-5 |
詳細
|
| Landogrozumab |
Landogrozumab |
1391726-30-9 |
詳細
|
| Tilavonemab |
TILAVONEMAB (替拉奈單抗 ) |
2096513-89-0 |
詳細
|
| Research Grade Ifabotuzumab |
IFABOTUZUMAB |
1234137-51-9 |
詳細
|
| Tezepelumab |
Tezepelumab |
1572943-04-4 |
詳細
|
| Olendalizumab |
Olendalizumab |
1337966-73-0 |
詳細
|
| Research Grade Gontivimab |
GONTIVIMAB (格替韋單抗 ) |
1257358-38-5 |
詳細
|
| Satralizumab |
薩特利珠單抗 |
1535963-91-7 |
詳細
|
| Xentuzumab |
珍妥珠單抗 |
1417158-65-6 |
詳細
|
| Refanezumab |
Refanezumab |
1233953-61-1 |
詳細
|
| Enoblituzumab |
MGA271 |
1353485-38-7 |
詳細
|
| Cabiralizumab |
Cabiralizumab |
1613144-80-1 |
詳細
|
| Ascrinvacumab |
Ascrinvacumab |
1463459-96-2 |
詳細
|
| Monalizumab |
莫那利珠單抗 |
1228763-95-8 |
詳細
|
| Plozalizumab |
Plozalizumab |
1610761-46-0 |
詳細
|
| Bleselumab |
Bleselumab |
1453067-91-8 |
詳細
|
| Opicinumab |
奧匹努單抗 |
1422268-07-2 |
詳細
|
| Clivatuzumab Tetraxetan |
Clivatuzumab Tetraxetan |
1462876-11-4 |
詳細
|
| Mirvetuximab |
Mirvetuximab |
1453084-36-0 |
詳細
|
| Navicixizumab |
Navicixizumab |
1638338-43-8 |
詳細
|
| Prezalumab |
Prezalumab |
1523164-68-2 |
詳細
|
| Laprituximab |
Laprituximab |
1622327-38-1 |
詳細
|
| Naratuximab |
那妥昔單抗 |
1622327-39-2 |
詳細
|
| Vadastuximab |
Vadastuximab |
1436390-63-4 |
詳細
|
| Rivabazumab |
Rivabazumab |
1627519-84-9 |
詳細
|
| Tamtuvetmab |
Tamtuvetmab |
1608122-71-9 |
詳細
|
| Blontuvetmab |
Blontuvetmab |
1608112-78-2 |
詳細
|
| Crotedumab |
Crotedumab |
1452387-69-7 |
詳細
|
| Vonlerolizumab |
Vonlerolizumab |
1638935-72-4 |
詳細
|
| Lanadelumab |
Lanadelumab |
1426055-14-2 |
詳細
|
| Timolumab |
Timolumab |
1073538-99-4 |
詳細
|
| Carotuximab |
Carotuximab |
1268714-50-6 |
詳細
|
| Domagrozumab |
Domagrozumab |
1629605-31-7 |
詳細
|
| Galcanezumab |
伽奈珠單抗 |
1578199-75-3 |
詳細
|
| Research Grade Setrusumab |
|
1847394-95-9 |
詳細
|
| Research Grade Apamistamab |
Iodine (131I) Apamistamab |
2097132-02-8 |
詳細
|
| Duvortuxizumab |
Duvortuxizumab |
1831098-91-9 |
詳細
|
| Rozanolixizumab |
洛利昔珠單抗 |
1584645-37-3 |
詳細
|
| Lupartumab |
Lupartumab |
1640971-88-5 |
詳細
|
| Eptinezumab |
依普奈珠單抗 |
1644539-04-7 |
詳細
|
| Elezanumab |
Elezanumab |
1791416-49-3 |
詳細
|